Live Breaking News & Updates on Nerv Technology Inc

Stay updated with breaking news from Nerv technology inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Minerva Neurosciences (NASDAQ:NERV) Upgraded by StockNews.com to "Hold"

StockNews.com upgraded shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) from a sell rating to a hold rating in a report published on Thursday. Minerva Neurosciences Stock Up 5.6 % Minerva Neurosciences stock traded up $0.43 during mid-day trading on Thursday, hitting $8.14. The company had a trading volume of 15,523 shares, compared to its […] ....

Minerva Neurosciences , Minerva Neurosciences Company Profile , Renaissance Technologies , Virtu Financial , Blackrock Inc , Minerva Neurosciences Inc , Jpmorgan Chase Co , Free Report , Get Free Report , New Drug Application , Minerva Neurosciences Daily , Nasdaq Nerv , Stocknews Com ,

Minerva Neurosciences, Inc. (NASDAQ:NERV) Short Interest Down 16.9% in October

Minerva Neurosciences, Inc. (NASDAQ:NERV – Get Free Report) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totalling 49,000 shares, a drop of 16.9% from the September 30th total of 59,000 shares. Approximately 1.0% of the shares of the stock are sold short. Based […] ....

Minerva Neurosciences , Minerva Neurosciences Inc , Renaissance Technologies , Virtu Financial , Jpmorgan Chase Co , Geode Capital Management , Get Free Report , Capital Management , New Drug Application , Minerva Neurosciences Daily , Nasdaq Nerv ,

Minerva Neurosciences (NASDAQ:NERV) Upgraded to "Hold" by StockNews.com

StockNews.com upgraded shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) from a sell rating to a hold rating in a research note published on Friday. Separately, HC Wainwright upped their price objective on shares of Minerva Neurosciences from $8.00 to $11.00 and gave the company a neutral rating in a report on Wednesday, August 2nd. […] ....

Minerva Neurosciences , Minerva Neurosciences Inc , Renaissance Technologies , Blackrock Inc , Geode Capital Management , Jpmorgan Chase Co , Virtu Financial , Free Report , Neurosciences Stock Down , Get Free Report , Capital Management , New Drug Application , Minerva Neurosciences Daily , Nasdaq Nerv , Stocknews Com ,

Minerva Neurosciences (NASDAQ:NERV) Lifted to Hold at StockNews.com

StockNews.com upgraded shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) from a sell rating to a hold rating in a research note published on Friday. Separately, HC Wainwright boosted their price target on shares of Minerva Neurosciences from $8.00 to $11.00 and gave the company a neutral rating in a report on Wednesday, August 2nd. […] ....

Minerva Neurosciences , Geode Capital Management , Renaissance Technologies , Minerva Neurosciences Company Profile , Minerva Neurosciences Inc , Jpmorgan Chase Co , Blackrock Inc , Free Report , Get Free Report , Capital Management , New Drug Application , Minerva Neurosciences Daily , Nasdaq Nerv , Stocknews Com ,

Minerva Neurosciences, Inc. (NASDAQ:NERV) Short Interest Down 20.3% in September

Minerva Neurosciences, Inc. (NASDAQ:NERV – Get Free Report) saw a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 59,000 shares, a decrease of 20.3% from the September 15th total of 74,000 shares. Based on an average trading volume of 45,200 shares, the days-to-cover ratio […] ....

Minerva Neurosciences , Minerva Neurosciences Inc , Virtu Financial , Renaissance Technologies , Minerva Neurosciences Company Profile , Blackrock Inc , Geode Capital Management , Get Free Report , Neurosciences Stock Down , Capital Management , New Drug Application , Minerva Neurosciences Daily , Nasdaq Nerv ,